AFT Pharmaceuticals (NZSE:AFT) Dividends Received: NZ$0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NZSE:AFT AFT Pharmaceuticals Ltd NZSE:AFT
96 GF Score
Price NZ$3.92
GF Value NZ$4.19
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is AFT Pharmaceuticals Dividends Received?

AFT Pharmaceuticals NZSE:AFT -0.51% 96 Dividends Received is NZ$0.0 Mil as of Mar. 2026. GuruFocus rates NZSE:AFT with a GF Score™ of 96/100 and a GF Value™ of NZ$4.19 (Fairly Valued). The stock has 4 warning signs investors should review.

AFT Pharmaceuticals's Dividends Received for the six months ended in Mar. 2026 was NZ$0.0 Mil.

AFT Pharmaceuticals's Dividends Received for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.0 Mil.

AFT Pharmaceuticals Dividends Received Related Terms

AFT Pharmaceuticals Dividends Received Historical Data

* Premium members only.

The historical data trend for AFT Pharmaceuticals's Dividends Received can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFT Pharmaceuticals Dividends Received Chart

AFT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividends Received
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AFT Pharmaceuticals Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Dividends Received Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NZSE:AFT
96GF Score
AFT Pharmaceuticals Ltd NZSE:AFT
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AFT Pharmaceuticals Dividends Received Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Dividends Received represents dividend received on the investment in the direct cash flow method.

Dividends Received for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividends Received →
What does a Dividends Received of NZ$0.0 Mil mean?
AFT Pharmaceuticals (NZSE:AFT) has a Dividends Received of NZ$0.0 Mil as of Mar. 2026. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for AFT Pharmaceuticals and its competitors.
Is AFT Pharmaceuticals' Dividends Received too high?
AFT Pharmaceuticals' current Dividends Received is NZ$0.0 Mil. Overall, AFT Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Dividends Received compare to ZTS and UTHR?
AFT Pharmaceuticals' Dividends Received of NZ$0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends Received for a Drug Manufacturers company?
A good Dividends Received depends on the Drug Manufacturers industry context. However, Dividends Received should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends Received mean?
A high Dividends Received can signal that a stock is expensive relative to its fundamentals. Dividends Received represents dividend received on the investment in direct cash flow method. View historical data for AFT Pharmaceuticals and its competitors. AFT Pharmaceuticals's current Dividends Received is NZ$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (NZSE:AFT) is currently considered Fairly Valued. The stock's GF Value™ is NZ$4.19, compared to a current price of NZ$3.92 — trading 6.4% below its estimated fair value. The current Dividends Received is NZ$0.0 Mil. AFT Pharmaceuticals' overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends Received calculated?
Dividends Received is calculated from a company's financial statements. For AFT Pharmaceuticals (NZSE:AFT), the current Dividends Received is NZ$0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?

Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued. The current stock price of NZ$3.92 is trading 6.4% below its estimated GF Value™ of NZ$4.19. GuruFocus considers AFT Pharmaceuticals to be Fairly Valued.

Key valuation signals for NZSE:AFT:

  • Dividends Received: NZ$0.0 Mil
  • GF Value™: NZ$4.19 vs. price of NZ$3.92 (6.4% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AFT Pharmaceuticals Business Description

Other Exchanges AFP:Australia
Address 129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
96GF Score

Get the complete analysis for NZSE:AFT

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$3.92
Price
NZ$4.19
GF Value